Angiotensin-converting enzyme 2: virus accomplice or host defender?

被引:0
|
作者
Wang Jiyan [1 ]
Chang Hongkai [1 ]
Qiao Yaya [1 ]
Sun Huanran [1 ]
Li Xichuan [6 ]
Yuan Shuofeng [10 ]
Zhang Shuai [17 ]
Shan Changliang [1 ]
机构
[1] State Key Laboratory of Emerging Infectious Diseases
[2] Carol Yu Centre for Infection  12. Department of Microbiology  13. Li Ka Shing Faculty of Medicine 
[3] School of Integrative Medicine
[4] Tianjin University of Traditional Chinese Medicine  19. Tianjin 301617
[5] State Key Laboratory of Medicinal Chemical Biology
[6] College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research  3. Nankai University  4. Tianjin 300350 
[7] Tianjin Key Laboratory of Animal and Plant Resistance
[8] College of Life Sciences  8. Tianjin Normal University  9. Tianjin 300387
关键词
ACE2; asymptomatic infection; COVID-19; metabolism; SARS-CoV-2;
D O I
暂无
中图分类号
R511 [病毒传染病];
学科分类号
100401 ;
摘要
Objective: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to social disruptions, mainly because we know too little about SARS-CoV-2.Methods and Results: In this study, we integrated RNA sequencing results and found that SARS-CoV-2 infection alters aerobic glycolysis, the oxidative pentose phosphate pathway (oxiPPP), and DNA replication in lung tissues and cells. However, the direction of metabolic flux and DNA replication are dominated by angiotensin-converting enzyme 2 (ACE2), a host cell-expressed viral receptor protein. More interestingly, although hosts with a high expression of ACE2 are more likely to be infected with SARS-CoV-2, the invading virus cannot perform nucleic acid replication well due to the restriction of glucose metabolism, eventually resulting in a prolonged infection cycle or infection failure.Conclusion: Our findings preliminarily explain the reasons for the emergence of asymptomatic infections at an early stage, which will provide assistance for the development of detection methods for diagnosing COVID-19.
引用
收藏
相关论文
共 50 条
  • [41] Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor
    d'Alessandro, Miriana
    Bergantini, Laura
    Perrone, Anna
    Cameli, Paolo
    Cameli, Matteo
    Prasse, Antje
    Plataroti, Dario
    Sestini, Piersante
    Bargagli, Elena
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 78 : 58 - 62
  • [42] Significance of vascular angiotensin-converting enzyme in the depressor mechanism by angiotensin-converting enzyme inhibitors.
    Fukuda, Y
    Takai, S
    Sakaguchi, M
    Jin, DN
    Miyazaki, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 138P - 138P
  • [43] Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
    Mitani, Sawane
    Yabuki, Akira
    Sawa, Mariko
    Chang, Hye-Sook
    Yamato, Osamu
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2014, 76 (01): : 45 - 50
  • [44] Imbalance Between Pulmonary Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Activity in Acute Respiratory Distress Syndrome
    Wosten-van Asperen, Roelie M.
    Bos, Albert P.
    Bem, Reinout A.
    Dierdorp, Barbara S.
    Dekker, Tamara
    van Goor, Harry
    Kamilic, Jelena
    van der Loos, Chris M.
    van den Berg, Elske
    Bruijn, Martijn
    van Woensel, Job B.
    Lutter, Rene
    PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (09) : E438 - E441
  • [45] Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
    Meurs, Kathryn M.
    Stern, Joshua A.
    Atkins, Clarke E.
    Adin, Darcy
    Aona, Brent
    Condit, Julia
    DeFrancesco, Teresa
    Reina-Doreste, Yamir
    Keene, Bruce W.
    Tou, Sandy
    Ward, Jessica
    Woodruff, Kathleen
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2017, 18 (04) : 1 - 4
  • [46] High expression of angiotensin-converting enzyme and angiotensin-converting enzyme 2 in preservation injury after liver transplantation in rats
    Xia, Chun-Yan
    Li, Ling
    Liu, Hui-Min
    Cong, Wen-Ming
    HEPATOLOGY RESEARCH, 2009, 39 (11) : 1118 - 1124
  • [47] In reply - Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (07) : 1553 - 1556
  • [48] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230
  • [49] Angiotensin-converting enzyme 2: a key enzyme in key organs
    Pagliaro, Pasquale
    Thairi, Cecilia
    Alloatti, Giuseppe
    Penna, Claudia
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (01) : 1 - 11
  • [50] ANGIOTENSIN AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    METS, B
    MILLER, ED
    BAILLIERES CLINICAL ANAESTHESIOLOGY, 1994, 8 (01): : 151 - 173